Market Performance - The three major A-share indices collectively rose on September 29, with the ChiNext Index increasing by 2.74% [1] - The total trading volume in the Shanghai and Shenzhen markets reached 21,781.43 billion yuan, an increase of over 12 billion yuan compared to the previous trading day [1] - More than 3,500 stocks closed higher, with 68 stocks hitting the daily limit up [1] Sector Performance - The leading sectors included metals such as zinc, nickel, and lead, while sectors like pork and military equipment restructuring saw significant declines [2] Institutional Ratings - A total of 21 buy ratings were issued by institutions today, covering 20 stocks, with three stocks receiving target price forecasts [3] - Stocks with buy ratings from institutions averaged a rise of 2.34%, outperforming the Shanghai Composite Index [4] Stock Highlights - Notable stocks that rose today included Lingyi Zhi Manufacturing and New Australia Holdings, with significant gains [5] - The top gainers included Feilihua, Luzhou Laojiao, and Huhua Electric, with increases of 5.24%, 4.3%, and 3.18% respectively [5] Institutional Buying and Selling - In the Dragon and Tiger list, 12 stocks saw net buying from institutions, with Tianqi Materials and Chuling Information receiving over 100 million yuan in net purchases [6] - The top net buying amounts included Tianqi Materials at 1 billion yuan and Lingyi Zhi Manufacturing at 987.78 million yuan [6] - Among the stocks sold by institutions, New Light Optoelectronics faced the highest net selling at 144 million yuan [7] Northbound Capital - Northbound funds saw net buying in 11 stocks, with Lingyi Zhi Manufacturing and Tianqi Materials leading the way [7] - Three stocks experienced net selling from northbound funds, with Wanxiang Qianchao facing a net sell of 105 million yuan [8] Company Announcements - Jingye Intelligent plans to acquire a 51% stake in Hefei Shengwen Information Technology for 1.08 billion yuan, aiming to enhance its military industry strategy [9] - Walton Technology is in the proposal stage for a project to enhance membrane materials and components, subject to internal approvals and market conditions [9] - ST Mingjiahui has received a court ruling for restructuring, which may lead to delisting risks if the restructuring fails [10] - Huayou Cobalt's subsidiary signed a supply agreement with LG Energy Solution for 76,000 tons of ternary precursor products from 2026 to 2030 [11] - China CRRC announced several major contracts totaling approximately 543.4 billion yuan, representing 22% of its projected 2024 revenue [11] - ST Mubang's actual controller is under investigation by the China Securities Regulatory Commission for failing to disclose non-operating fund transactions [11]

Core Viewpoint - The actual controller of *ST Muban, Liao Zhiyuan, is under investigation by the China Securities Regulatory Commission (CSRC) for failing to disclose non-operating fund transactions as required by law [1][3]. Group 1: Regulatory Actions - Liao Zhiyuan received a notice from the CSRC on September 29, 2025, regarding the investigation for non-disclosure of non-operating fund transactions [1]. - The company had previously received a notice from the CSRC on July 25, 2025, for suspected false disclosures in annual reports and other periodic financial reports [3]. - The company will cooperate with the CSRC and adhere to information disclosure obligations [3]. Group 2: Financial Performance and Risks - The company reported a net loss of 213 million yuan for the first half of 2025, with total revenue of 141 million yuan [4]. - The company faces delisting risks due to a negative net profit for the fiscal year 2024 and revenue below 300 million yuan [4]. - The stock was placed under risk warning on May 6, 2025, due to financial performance issues and internal control deficiencies [4]. Group 3: Stock Performance - The stock price of *ST Muban experienced a significant increase, with a cumulative rise of 21.71% over four consecutive trading days from September 24 to September 29, 2025 [3]. - The stock has seen an overall increase of over 50% since September 2025 [8]. - The company issued a risk warning regarding the rapid increase in stock price, which may not align with its fundamental performance [3].

Mergers and Acquisitions - DiAo Micro plans to acquire equity in Rongpai Semiconductor through a combination of issuing shares and cash payment, with the stock suspended for up to 10 trading days [1] - Jingye Intelligent intends to purchase 51% of Hefei Shengwen for 108 million yuan, aiming to enhance its strategic presence in the military sector [2] - Guolin Technology is planning a cash acquisition of 91.07% of Xinjiang Kailianjie, which specializes in the production of maleic anhydride, potentially creating a synergistic relationship with its existing business [3] Shareholding Changes - Erkang Pharmaceutical's controlling shareholder plans to reduce holdings by up to 42 million shares, representing 2.04% of the total share capital [4] - Senba Sensor's actual controller's associated party intends to reduce holdings by no more than 308.69 thousand shares, accounting for 1.09% of the total share capital [5] - Zhiyang Innovation's controlling shareholder and associated parties plan to reduce holdings by up to 422.5 thousand shares, which is 1.82% of the total share capital, during a specified period [6] Regulatory Issues - Youkeshu announced that three shareholders are under investigation by the China Securities Regulatory Commission for failing to disclose significant information [7] - *ST Xingnong received a notice from the China Securities Regulatory Commission regarding an investigation for suspected information disclosure violations, while its operations remain normal [8] - *ST Mubang's actual controller is also under investigation by the China Securities Regulatory Commission for failing to disclose non-operational fund transactions [10]

编辑 王进雨 新京报贝壳财经讯 9月29日，*ST沐邦公告称，公司实际控制人廖志远于2025年9月29日收到中国证监会 《立案告知书》，因廖志远涉嫌未按规定披露非经营性资金往来，根据相关法律法规，中国证监会决定 对廖志远立案。公司将积极配合中国证监会的相关工作，并严格履行信息披露义务。 ...

【导读】*ST沐邦及其实控人廖志远，相继被中国证监会立案 9月29日晚间，*ST沐邦发布公告，中国证监会决定对公司实控人廖志远立案，其涉嫌未按规定披露非经营性资金往来。 7月25日，*ST沐邦收到中国证监会下发的《立案告知书》，中国证监会决定对公司立案，主要是公司涉嫌年报等定期报告财务数据虚假披露等违法行 为。 9月29日晚间，*ST沐邦发布公告称，公司9月24日至9月29日连获4个涨停板，严重脱离基本面，存在下跌风险。截至9月29日收盘，*ST沐邦股价报9.42元/ 股，涨幅达5.02%，总市值为40.85亿元。 "80后"实控人被立案 此前监管部门查明资金占用问题 9月29日，廖志远收到中国证监会下发的《立案告知书》显示，因其涉嫌未按规定披露非经营性资金往来，中国证监会决定对其立案。 廖志远生于1987年，历任中贤建设集团有限公司总裁、大成国联建设有限公司董事长兼总经理；2021年11月至2022年9月任*ST沐邦总经理，2021年11月 至今任*ST沐邦董事长。 目前，外界无法知晓廖志远被立案涉及哪些具体事项，但是上交所在8月份对*ST沐邦及廖志远等有关责任人先后予以公开谴责、通报批评。 经查明，*ST ...

Group 1 - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters of 2025, representing a year-on-year increase of 1531% to 1673% [1] - China CNR Corporation signed major contracts totaling approximately 54.34 billion yuan, accounting for 22% of its expected revenue for 2024 [1] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan, a year-on-year increase of 34.1% [2] Group 2 - Fulian Precision plans to increase capital in its subsidiary Jiangxi Shenghua with a total investment of 35.63 billion yuan, which is expected to constitute a major asset restructuring [3] - Aimeike has obtained a drug registration certificate for Minoxidil topical solution, which is used for treating male pattern baldness [4] - Guolin Technology is planning to acquire 91.07% of Kailianjie’s equity for cash, which is expected to constitute a major asset restructuring [5] Group 3 - Baicheng Co. plans to purchase 55% of Shanghai Canxi Engineering Equipment Co. and will suspend trading of its stock starting September 30, 2025 [6][7] - Diaowei is planning to acquire equity in Rongpai Semiconductor and has suspended trading of its stock [8] - Xiatun New Energy signed a strategic cooperation framework agreement with Zhongwei Co. to establish a long-term partnership in the supply chain for solid-state lithium battery materials [9] Group 4 - Lingyi Zhi Manufacturing is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its international strategy [10] - Baicheng Pharmaceutical received clinical trial approval for its innovative drug BIOS-0623-Z4, which targets cancer pain treatment [11] - Weide Information announced a preliminary transfer price of 40.33 yuan per share, representing a 26% discount to its closing price [12] Group 5 - Huayou Cobalt's subsidiary signed contracts with LGES for the supply of 76,000 tons of ternary precursor materials and 88,000 tons of ternary cathode materials from 2026 to 2030 [13] - Hubei Energy signed a cooperation agreement with the Xiangyang Municipal Government to invest 26.7 billion yuan in clean energy projects [14]

7月25日，*ST沐邦收到中国证监会下发的《立案告知书》，中国证监会决定对公司立案，主要是公司涉嫌年报等定期报告财务数据虚假披露等违法行 为。 【导读】*ST沐邦及其实控人廖志远，相继被中国证监会立案 9月29日晚间，*ST沐邦（603398）发布公告，中国证监会决定对公司实控人廖志远立案，其涉嫌未按规定披露非经营性资金往来。 9月29日晚间，*ST沐邦发布公告称，公司9月24日至9月29日连获4个涨停板，严重脱离基本面，存在下跌风险。截至9月29日收盘，*ST沐邦股价报9.42元/ 股，涨幅达5.02%，总市值为40.85亿元。 "80后"实控人被立案 此前监管部门查明资金占用问题 廖志远生于1987年，历任中贤建设集团有限公司总裁、大成国联建设有限公司董事长兼总经理；2021年11月至2022年9月任*ST沐邦总经理，2021年11月 至今任*ST沐邦董事长。 9月29日，廖志远收到中国证监会下发的《立案告知书》显示，因其涉嫌未按规定披露非经营性资金往来，中国证监会决定对其立案。 目前，外界无法知晓廖志远被立案涉及哪些具体事项，但是上交所在8月份对*ST沐邦及廖志远等有关责任人先后予以公开谴责、通报批评。 ...

【 导读 】*ST沐邦 及其 实控人廖志远， 相继被中国证监会 立案 中国基金报记者 闻言 9月29日 晚间 ，*ST沐邦 发布 公告， 中国证监会决定对 公司实控人廖志远 立案， 其 涉嫌未按规定披露非经营性资金往来。 中国基金报问讯 更快 更准 更有料 "80后"实控人被立案 此前监管部门查明资金占用问题 2025-09-29 17:51:10 星期一 【*ST沐邦:实控人因信披问题 被证监会立案】 中国基金报9月29日电，*ST沐邦（603398.S H) 公告,公司实际控制人廖志远于2025年9月 29日收到中国证监会《立案告知书》，因其涉 嫌未按规定披露非经营性资金往来，证监会决 定对其立案。 廖志远及公司将积极配合调查， 并严格履行信息披露义务。敬请投资者关注风 险。 长按右侧二维码 阅读原文 7月25日，*ST沐邦收到中国证监会 下发的 《立案告知书》 ，中国证监会决定对公司立案，主要是公司 涉嫌年报等定期报告财务数据虚 假披露等违法行为。 9月29日晚间， *ST沐邦 发布公告称，公司9月24日至9月29日连获4个涨停 板 ，严重脱离基本面，存在下跌风险。截至9月29日收盘， *ST沐邦 股价 ...

*ST沐邦（603398）(603398.SH)发布公告，公司实际控制人廖志远先生于2025年9月29日收到中国证券 监督管理委员会(简称"中国证监会")《立案告知书》(编号：证监立案字0252025005号)。因廖志远先生 涉嫌未按规定披露非经营性资金往来，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》 等法律法规，中国证监会决定对廖志远先生立案。 ...

Macro Dynamics - As of June 2025, China's banking sector has foreign financial assets totaling $17,721 billion and foreign liabilities of $15,377 billion, resulting in a net foreign asset of $2,344 billion. The net liabilities in RMB amount to $3,171 billion, while net assets in foreign currencies total $5,515 billion. The breakdown of foreign financial assets shows that loans and deposits account for $10,638 billion (60%), bonds for $4,526 billion (26%), and other assets for $2,557 billion (14%) [2]. Visa and Immigration Policies - China has introduced a new K visa category aimed at promoting exchanges and cooperation among young scientific and technological talents, with details to be announced by Chinese embassies and consulates [3]. - Starting September 29, South Korea has implemented a visa waiver policy for group tourists from China, allowing groups of three or more to enter without a visa for up to 15 days [5]. Financial Institutions - Roadhuas Securities has been fined HKD 2.1 million by the Hong Kong Securities and Futures Commission for improper handling of client funds, which included failing to maintain sufficient funds in independent client accounts on 12 occasions between February 2021 and July 2022 [6]. Market Data - On September 29, the A-share market saw all major indices rise, with the Shanghai Composite Index increasing by 0.9%, the Shenzhen Component by 2.05%, and the ChiNext Index by 2.74%. The total trading volume across the Shanghai and Shenzhen exchanges was CNY 21,781 billion, an increase of CNY 120 billion from the previous day [7]. - The margin financing balance in the two markets decreased by CNY 19.253 billion as of September 26, with the Shanghai Stock Exchange reporting a balance of CNY 12,188.55 billion and the Shenzhen Stock Exchange reporting CNY 11,815.43 billion [8]. Company Dynamics - China CNR Corporation announced several major contracts signed between July and September 2025, totaling approximately CNY 543.4 billion, which represents about 22% of the company's projected revenue for 2024 [11]. - The actual controller of *ST Muban has been placed under investigation by the China Securities Regulatory Commission for failing to disclose non-operational fund transactions, with the stock experiencing a 21.71% increase over four consecutive trading days [12]. - Visa has appointed Elaine Chang as the new president for the Greater China region, succeeding Shirley Yu, who is set to retire at the end of the year [13]. - JD Health announced the resignation of its CEO, Jin Enlin, effective September 29, 2025, with Cao Dong appointed as the new CEO [14]. - Hainan Duty-Free Company has increased its registered capital from CNY 1.2 billion to CNY 1.7 billion, marking a 42% increase [15][16]. - AstraZeneca plans to list its shares on the New York Stock Exchange while retaining its headquarters in the UK [17]. - XGIMI Technology has submitted a listing application to the Hong Kong Stock Exchange, with CICC as the exclusive sponsor [18].